Magnesium orotate in severe congestive heart failure (MACH) (DOI:10.1016/j.ijcard.2007.11.022);Magnesium orotate in severe congestive heart failure (MACH)

International Journal of Cardiology

Volumn 131, Issue 2, 2009, Pages 293-295

  Stepura, O B ^a   Martynow, A I ^b  

^a Russian University of Medicine   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Adjuvant therapy; Congestive heart failure; Magnesium; Magnesium orotate; Orotic acid

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; OROTATE MAGNESIUM;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; HEPATOMEGALY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 57549105524     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.01.047     Document Type: Erratum

References (4)

1. Gartside P.S., and Glueck C.J. The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. J Am Coll Nutr 14 (1995) 71-79
2. Richards S.M., Conyers R.A., Fisher J.L., and Rosenfeldt F.L. Cardioprotection by orotic acid: metabolism and mechanism of action. J Mol Cell Cardiol 29 (1997) 3239-3250
3. Rosenfeldt F.L. Metabolic supplementation with orotic acid and magnesium orotate. Cardiovasc Drugs Ther 12 Suppl 2 (1998) 147-152
4. Classen H.G. Magnesium orotate-experimental and clinical evidence. Rom J Intern Med 42 (2004) 491-501